Trastuzumab and Tucatinib
About
Membership operator: AND
Therapies: 2
Therapies
Trastuzumab (tx:ncit:C1647)
Tucatinib (tx:ncit:C77896)
Therapeutic response
Precision oncology relationships for therapeutic response involving this therapy group.
Organizations
Biomarkers
Cancer types
Therapies
| Organizations | Biomarkers | Cancer types | Therapies | |
|---|---|---|---|---|
| FDA (2) | HER2-positive, Wild type KRAS, Wild type NRAS | Colorectal Adenocarcinoma | Trastuzumab, Tucatinib |